| Literature DB >> 29622647 |
Hiroki Abe1, Susumu Jitsuki1, Waki Nakajima1, Yumi Murata2, Aoi Jitsuki-Takahashi1, Yuki Katsuno1, Hirobumi Tada1, Akane Sano1, Kumiko Suyama1, Nobuyuki Mochizuki1,3,4, Takashi Komori1,3,4, Hitoshi Masuyama1,3,4, Tomohiro Okuda3,4, Yoshio Goshima5, Noriyuki Higo2, Takuya Takahashi6.
Abstract
Brain damage such as stroke is a devastating neurological condition that may severely compromise patient quality of life. No effective medication-mediated intervention to accelerate rehabilitation has been established. We found that a small compound, edonerpic maleate, facilitated experience-driven synaptic glutamate AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic-acid) receptor delivery and resulted in the acceleration of motor function recovery after motor cortex cryoinjury in mice in a training-dependent manner through cortical reorganization. Edonerpic bound to collapsin-response-mediator-protein 2 (CRMP2) and failed to augment recovery in CRMP2-deficient mice. Edonerpic maleate enhanced motor function recovery from internal capsule hemorrhage in nonhuman primates. Thus, edonerpic maleate, a neural plasticity enhancer, could be a clinically potent small compound with which to accelerate rehabilitation after brain damage.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29622647 DOI: 10.1126/science.aao2300
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728